Mogroside
V (MV), a sweetener, is one of the major components inSiraitia grosvenorii. In our research, after in vitro incubation with MV for 24 h, the human gut microbiota
diversity changed, with an enrichment of the genera Bacteroides, Lactobacillus, Prevotella, Megasphaera, and Olsenella and the inhibition
of Clostridium XlVa, Dorea, and Desulfovibrio. Moreover, the synthesis of short-chain fatty
acids, such as acetate, propionate, and butyrate, was increased by
gut microbiota. According to ultraperformance liquid chromatography–mass
spectrometry (UPLC-MS) analysis, MV was decomposed into secondary
mogrosides, such as mogroside II/I and mogrol, by gut microbiota.
Enhanced antioxidant abilities of the metabolites were found in the
broth.
The results suggested that MV, as a potential prebiotic, could benefit
human health through its interaction with gut microbiota.